Results 161 to 170 of about 45,170 (249)

The State of Shared Decision-Making in Immune Thrombocytopenia: A Narrative Review and Health Care Provider Perspective. [PDF]

Health Sci Rep
Jain S, Kuhel K, Cree R, Tarantino MD.
europepmc   +1 more source

Evolving Paradigms in the Management of Primary Immune Thrombocytopenia in Adults: From Corticosteroids to Targeted Therapies. [PDF]

Mediterr J Hematol Infect Dis
Martino M, Giordano L, Greve MB, Marafioti V, Alati C.   +4 more
europepmc   +1 more source

Immune thrombocytopenic purpura (ITP) and breast cancer. Does adjuvant therapy for breast cancer improve platelet counts in ITP?

, 2009
Although both breast cancer and immune thrombocytopenic purpura (ITP) are common conditions, the simultaneous coexistence of these two diseases is rare.
S Baron-Hay (13605427), Mustafa Khasraw (13078896)   +1 more
core  

Guideline on the emergency management of critical bleeding in patients with immune thrombocytopenia. [PDF]

Blood Adv
Chowdhury SR, Sirotich E, Guyatt G, Modi D, Cuker A, Breakey VR, Grace RF, Pai M, Beck CE, Yan JW, Porter S, Kang M, Webert KE, O'Connor C, Pruitt B, MacWhirter-DiRaimo J, Paynter D, Strachan G, St John M, Molnar L, Arnold DM.   +20 more
europepmc   +1 more source

Cost-effectiveness analysis of eltrombopag, hetrombopag and romiplostim for second-line treatment of primary immune thrombocytopenia in China. [PDF]

Front Med (Lausanne)
Chen X, Liu Y, Zhang J, Xu R, Guo C.
europepmc   +1 more source

Romiplostim during pregnancy in refractory primary immune thrombocytopenia: Literature review and case series. [PDF]

Ther Adv Hematol
Weinstein Mezan D, Shekel E, Roth B, Kalish Y, Kabiri D.   +4 more
europepmc   +1 more source

Design of a modified platelet immunofluorescence test to assess platelet-reactive antibody burden and its association with platelet functional exhaustion and clinical features in chronic immune thrombocytopenia. [PDF]

Br J Haematol
Hosseini E, Heidari N, Faranoush M, Pezeshki SMS, Gardiner EE, Ghasemzadeh M.   +5 more
europepmc   +1 more source

Reprogramming rather than depleting immunity: Targeting the CD38-NAD⁺ axis in antibody-mediated autoimmunity. [PDF]

Clin Transl Med
Li H, Wei J, Zhang L.
europepmc   +1 more source

Transient ST-segment elevation following coronary artery bypass grafting in a patient with immune thrombocytopenia treated with romiplostim: a case report. [PDF]

Egypt Heart J
Ansari ZR, Hamdulay ZA, Khan A, Jain S, Hamdulay M, Kothawala A.   +5 more
europepmc   +1 more source

Pathophysiology of ITP

Blood & Vessel, 1975
KURAMOTO, Atsushi, IHARA, Akihiro, OKITA, Hajime, TAKETOMI, Yoshisuke, FUJIMURA, Kingo, IMAOKA, Teiji   +5 more
openaire   +2 more sources